Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.65% | 1.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.65% | 1.80% | |||
| Cost of Revenue | -35.06% | 14.91% | |||
| Gross Profit | -2.49% | -2.54% | |||
| SG&A Expenses | -25.99% | 46.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.22% | 17.96% | |||
| Operating Income | -3.28% | -41.12% | |||
| Income Before Tax | -2.63% | -39.61% | |||
| Income Tax Expenses | -60.61% | 9.92% | |||
| Earnings from Continuing Operations | 44.48% | -55.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.48% | -55.79% | |||
| EBIT | -3.28% | -41.12% | |||
| EBITDA | -5.94% | -35.64% | |||
| EPS Basic | 44.04% | -55.86% | |||
| Normalized Basic EPS | -2.94% | -39.69% | |||
| EPS Diluted | 44.24% | -56.17% | |||
| Normalized Diluted EPS | -2.76% | -39.59% | |||
| Average Basic Shares Outstanding | 0.32% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.14% | -0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||